Healthcare Fraud Enforcement Under a New Administration: Increasing Criminal and Civil Actions, Mitigating Client Risk
A live 90-minute CLE video webinar with interactive Q&A
This CLE webinar will examine the new administration's focus on healthcare fraud, agency priorities, and the impact this will have on healthcare entities. The panel will discuss DOJ's increased focus on criminal enforcement action as well as civil enforcement trends. The panel will also look at HHS-OIG's first semiannual report to Congress under the new administration and address what may be expected in terms of agency enforcement. Finally, the panel will offer best practices for helping healthcare clients remain compliant under increased government scrutiny.
Outline
- Introduction
- New administration's focus on healthcare fraud
- DOJ
- Criminal enforcement and the White-Collar Enforcement Plan
- Healthcare fraud focus
- Whistleblower program
- Self-disclosure
- Civil enforcement trends
- Criminal enforcement and the White-Collar Enforcement Plan
- HHS-OIG
- First semiannual report to Congress under new administration
- Medicare Advantage
- Impact on healthcare entities
- Strengthening compliance programs
- Practitioner takeaways
Benefits
The panel will review these and other key issues:
- How has the DOJ indicated an increased focus on healthcare fraud, particularly relating to criminal enforcement actions?
- What does HHS-OIG's first semiannual report to Congress under the new administration indicate as to its enforcement focus?
- What civil and criminal enforcement trends may healthcare entities expect under the new administration?
- What are best practices for assisting healthcare clients with strengthening their compliance programs under increased government scrutiny?
Faculty
Denise M. Barnes
Member
Bass, Berry & Sims
Ms. Barnes counsels clients in high-stakes matters related to fraud allegations, including in healthcare, federal... | Read More
Ms. Barnes counsels clients in high-stakes matters related to fraud allegations, including in healthcare, federal contract procurement, and securities and financial services. A former trial attorney with the U.S. DOJ, she has extensive experience handling issues related to compliance, white-collar and regulatory investigations, and complex commercial litigation. Ms. Barnes represents businesses in public and non-public investigations, regulatory inquiries, and proceedings involving federal and state agencies. She frequently assists clients navigating government investigations related to allegations arising under the False Claims Act, Anti-Kickback Statute, Stark Law, and FIRREA. Ms. Barnes is also a recognized leader in her practice, frequently participating in various speaking engagements and authoring articles on critical topics such as cybersecurity, government contract billing, financial data rights, and developments related to the FCA.
Close
Jonathan A. Porter
Partner
Husch Blackwell
Mr. Porter focuses on white collar criminal defense, federal investigations brought under the False Claims Act, and... | Read More
Mr. Porter focuses on white collar criminal defense, federal investigations brought under the False Claims Act, and litigation against the government and whistleblowers, with an emphasis on matters within the healthcare industry. As a former federal prosecutor with the DOJ, he was a key member of multiple international healthcare fraud takedowns and prosecuted a series of high-profile financial crime cases. Mr. Porter also handled major civil investigations and litigation against companies and individuals under the False Claims Act, resulting in record-breaking settlements and judgments. He now uses that experience to guide clients through federal investigations of all kinds, to litigate cases against and involving the government, and to run effective and right-sized internal investigations for corporations. Many of Mr. Porter’s clients are in the healthcare industry, including health systems, physician groups, and other healthcare companies, along with medical professionals and executives. He serves as a vice chair of the American Health Law Association’s Fraud and Abuse Practice Group.
CloseEarly Discount (through 08/01/25)